Wall Street analysts expect Proto Labs Inc (NYSE:PRLB) to report $115.10 million in sales for the current quarter, according to Zacks. Two analysts have made estimates for Proto Labs’ earnings. Proto Labs posted sales of $94.18 million in the same quarter last year, which would indicate a positive year over year growth rate of 22.2%. The business is expected to announce its next earnings report on Thursday, February 14th.

According to Zacks, analysts expect that Proto Labs will report full year sales of $447.91 million for the current fiscal year, with estimates ranging from $447.90 million to $447.92 million. For the next year, analysts anticipate that the firm will report sales of $503.86 million, with estimates ranging from $496.21 million to $511.50 million. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for Proto Labs.

Proto Labs (NYSE:PRLB) last issued its quarterly earnings data on Thursday, October 25th. The industrial products company reported $0.86 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.21. Proto Labs had a net margin of 16.76% and a return on equity of 14.31%. The business had revenue of $115.43 million during the quarter, compared to analysts’ expectations of $112.53 million.

A number of analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of Proto Labs from a “hold” rating to a “buy” rating and set a $134.00 price objective for the company in a research note on Thursday, November 1st. Berenberg Bank assumed coverage on shares of Proto Labs in a research note on Wednesday, November 14th. They issued a “buy” rating and a $159.00 price objective for the company. Three research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $117.25.

Shares of Proto Labs stock traded up $3.02 on Friday, reaching $121.12. The stock had a trading volume of 87,595 shares, compared to its average volume of 159,936. Proto Labs has a fifty-two week low of $91.30 and a fifty-two week high of $166.60. The stock has a market capitalization of $3.28 billion, a price-to-earnings ratio of 62.76, a PEG ratio of 1.36 and a beta of 1.46.

In related news, CFO John Way sold 8,000 shares of the company’s stock in a transaction on Monday, September 24th. The shares were sold at an average price of $159.10, for a total transaction of $1,272,800.00. Following the completion of the transaction, the chief financial officer now directly owns 30,503 shares in the company, valued at approximately $4,853,027.30. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director John B. Goodman sold 1,113 shares of the company’s stock in a transaction on Friday, September 14th. The shares were sold at an average price of $162.95, for a total transaction of $181,363.35. Following the transaction, the director now owns 12,655 shares of the company’s stock, valued at $2,062,132.25. The disclosure for this sale can be found here. Insiders sold 23,934 shares of company stock valued at $3,663,441 over the last 90 days. 0.64% of the stock is owned by corporate insiders.

Large investors have recently added to or reduced their stakes in the stock. DekaBank Deutsche Girozentrale acquired a new position in Proto Labs during the 3rd quarter valued at $109,000. Harvest Fund Management Co. Ltd acquired a new position in Proto Labs during the 3rd quarter valued at $161,000. Nwam LLC acquired a new position in Proto Labs during the 2nd quarter valued at $201,000. Meeder Asset Management Inc. raised its stake in Proto Labs by 342.6% during the 2nd quarter. Meeder Asset Management Inc. now owns 1,735 shares of the industrial products company’s stock valued at $206,000 after purchasing an additional 1,343 shares during the last quarter. Finally, Cue Financial Group Inc. acquired a new position in Proto Labs during the 3rd quarter valued at $227,000. Hedge funds and other institutional investors own 94.75% of the company’s stock.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce enabled digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets.

See Also: Stock Symbols Definition, Examples, Lookup

Get a free copy of the Zacks research report on Proto Labs (PRLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.